Report Detail

Request for Sample of this report

Service & Software Global Life Science CDMO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4578524
    • |
  • 29 March, 2024
    • |
  • Global
    • |
  • 125 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Life Science CDMO market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Life Science CDMO industry chain, the market status of Pharmaceutical (Active Pharmaceutical Ingredient (API) CDMO, Biologics CDMO), Clinical (Active Pharmaceutical Ingredient (API) CDMO, Biologics CDMO), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Life Science CDMO.
Regionally, the report analyzes the Life Science CDMO markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Life Science CDMO market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Life Science CDMO market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Life Science CDMO industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Active Pharmaceutical Ingredient (API) CDMO, Biologics CDMO).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Life Science CDMO market.
Regional Analysis: The report involves examining the Life Science CDMO market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Life Science CDMO market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Life Science CDMO:
Company Analysis: Report covers individual Life Science CDMO players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Life Science CDMO This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical, Clinical).
Technology Analysis: Report covers specific technologies relevant to Life Science CDMO. It assesses the current state, advancements, and potential future developments in Life Science CDMO areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Life Science CDMO market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Life Science CDMO market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Active Pharmaceutical Ingredient (API) CDMO
Biologics CDMO
Finished Dosage Form (FDF) CDMO
Others
Market segment by Application
Pharmaceutical
Clinical
Research
Market segment by players, this report covers
Lonza Group
Thermo Fisher Scientific
Catalent
WuXi Biologics
Samsung Biologics
Siegfried
Fujifilm Diosynth Biotechnologies
Lars Petersen
Recipharm
Boehringer Ingelheim
MilliporeSigma
Aenova Group
AGC Parma Chemicals
GenScript
Novartis
Sai Life Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Life Science CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Life Science CDMO, with revenue, gross margin and global market share of Life Science CDMO from 2019 to 2024.
Chapter 3, the Life Science CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Life Science CDMO market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Life Science CDMO.
Chapter 13, to describe Life Science CDMO research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Life Science CDMO
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Life Science CDMO by Type
    • 1.3.1 Overview: Global Life Science CDMO Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Life Science CDMO Consumption Value Market Share by Type in 2023
    • 1.3.3 Active Pharmaceutical Ingredient (API) CDMO
    • 1.3.4 Biologics CDMO
    • 1.3.5 Finished Dosage Form (FDF) CDMO
    • 1.3.6 Others
  • 1.4 Global Life Science CDMO Market by Application
    • 1.4.1 Overview: Global Life Science CDMO Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pharmaceutical
    • 1.4.3 Clinical
    • 1.4.4 Research
  • 1.5 Global Life Science CDMO Market Size & Forecast
  • 1.6 Global Life Science CDMO Market Size and Forecast by Region
    • 1.6.1 Global Life Science CDMO Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Life Science CDMO Market Size by Region, (2019-2030)
    • 1.6.3 North America Life Science CDMO Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Life Science CDMO Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Life Science CDMO Market Size and Prospect (2019-2030)
    • 1.6.6 South America Life Science CDMO Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Life Science CDMO Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Lonza Group
    • 2.1.1 Lonza Group Details
    • 2.1.2 Lonza Group Major Business
    • 2.1.3 Lonza Group Life Science CDMO Product and Solutions
    • 2.1.4 Lonza Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Lonza Group Recent Developments and Future Plans
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific Life Science CDMO Product and Solutions
    • 2.2.4 Thermo Fisher Scientific Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.3 Catalent
    • 2.3.1 Catalent Details
    • 2.3.2 Catalent Major Business
    • 2.3.3 Catalent Life Science CDMO Product and Solutions
    • 2.3.4 Catalent Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Catalent Recent Developments and Future Plans
  • 2.4 WuXi Biologics
    • 2.4.1 WuXi Biologics Details
    • 2.4.2 WuXi Biologics Major Business
    • 2.4.3 WuXi Biologics Life Science CDMO Product and Solutions
    • 2.4.4 WuXi Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 WuXi Biologics Recent Developments and Future Plans
  • 2.5 Samsung Biologics
    • 2.5.1 Samsung Biologics Details
    • 2.5.2 Samsung Biologics Major Business
    • 2.5.3 Samsung Biologics Life Science CDMO Product and Solutions
    • 2.5.4 Samsung Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Samsung Biologics Recent Developments and Future Plans
  • 2.6 Siegfried
    • 2.6.1 Siegfried Details
    • 2.6.2 Siegfried Major Business
    • 2.6.3 Siegfried Life Science CDMO Product and Solutions
    • 2.6.4 Siegfried Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Siegfried Recent Developments and Future Plans
  • 2.7 Fujifilm Diosynth Biotechnologies
    • 2.7.1 Fujifilm Diosynth Biotechnologies Details
    • 2.7.2 Fujifilm Diosynth Biotechnologies Major Business
    • 2.7.3 Fujifilm Diosynth Biotechnologies Life Science CDMO Product and Solutions
    • 2.7.4 Fujifilm Diosynth Biotechnologies Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans
  • 2.8 Lars Petersen
    • 2.8.1 Lars Petersen Details
    • 2.8.2 Lars Petersen Major Business
    • 2.8.3 Lars Petersen Life Science CDMO Product and Solutions
    • 2.8.4 Lars Petersen Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Lars Petersen Recent Developments and Future Plans
  • 2.9 Recipharm
    • 2.9.1 Recipharm Details
    • 2.9.2 Recipharm Major Business
    • 2.9.3 Recipharm Life Science CDMO Product and Solutions
    • 2.9.4 Recipharm Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Recipharm Recent Developments and Future Plans
  • 2.10 Boehringer Ingelheim
    • 2.10.1 Boehringer Ingelheim Details
    • 2.10.2 Boehringer Ingelheim Major Business
    • 2.10.3 Boehringer Ingelheim Life Science CDMO Product and Solutions
    • 2.10.4 Boehringer Ingelheim Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.11 MilliporeSigma
    • 2.11.1 MilliporeSigma Details
    • 2.11.2 MilliporeSigma Major Business
    • 2.11.3 MilliporeSigma Life Science CDMO Product and Solutions
    • 2.11.4 MilliporeSigma Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 MilliporeSigma Recent Developments and Future Plans
  • 2.12 Aenova Group
    • 2.12.1 Aenova Group Details
    • 2.12.2 Aenova Group Major Business
    • 2.12.3 Aenova Group Life Science CDMO Product and Solutions
    • 2.12.4 Aenova Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Aenova Group Recent Developments and Future Plans
  • 2.13 AGC Parma Chemicals
    • 2.13.1 AGC Parma Chemicals Details
    • 2.13.2 AGC Parma Chemicals Major Business
    • 2.13.3 AGC Parma Chemicals Life Science CDMO Product and Solutions
    • 2.13.4 AGC Parma Chemicals Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 AGC Parma Chemicals Recent Developments and Future Plans
  • 2.14 GenScript
    • 2.14.1 GenScript Details
    • 2.14.2 GenScript Major Business
    • 2.14.3 GenScript Life Science CDMO Product and Solutions
    • 2.14.4 GenScript Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 GenScript Recent Developments and Future Plans
  • 2.15 Novartis
    • 2.15.1 Novartis Details
    • 2.15.2 Novartis Major Business
    • 2.15.3 Novartis Life Science CDMO Product and Solutions
    • 2.15.4 Novartis Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Novartis Recent Developments and Future Plans
  • 2.16 Sai Life Sciences
    • 2.16.1 Sai Life Sciences Details
    • 2.16.2 Sai Life Sciences Major Business
    • 2.16.3 Sai Life Sciences Life Science CDMO Product and Solutions
    • 2.16.4 Sai Life Sciences Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Sai Life Sciences Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Life Science CDMO Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Life Science CDMO by Company Revenue
    • 3.2.2 Top 3 Life Science CDMO Players Market Share in 2023
    • 3.2.3 Top 6 Life Science CDMO Players Market Share in 2023
  • 3.3 Life Science CDMO Market: Overall Company Footprint Analysis
    • 3.3.1 Life Science CDMO Market: Region Footprint
    • 3.3.2 Life Science CDMO Market: Company Product Type Footprint
    • 3.3.3 Life Science CDMO Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Life Science CDMO Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Life Science CDMO Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Life Science CDMO Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Life Science CDMO Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Life Science CDMO Consumption Value by Type (2019-2030)
  • 6.2 North America Life Science CDMO Consumption Value by Application (2019-2030)
  • 6.3 North America Life Science CDMO Market Size by Country
    • 6.3.1 North America Life Science CDMO Consumption Value by Country (2019-2030)
    • 6.3.2 United States Life Science CDMO Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Life Science CDMO Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Life Science CDMO Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Life Science CDMO Consumption Value by Type (2019-2030)
  • 7.2 Europe Life Science CDMO Consumption Value by Application (2019-2030)
  • 7.3 Europe Life Science CDMO Market Size by Country
    • 7.3.1 Europe Life Science CDMO Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Life Science CDMO Market Size and Forecast (2019-2030)
    • 7.3.3 France Life Science CDMO Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Life Science CDMO Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Life Science CDMO Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Life Science CDMO Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Life Science CDMO Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Life Science CDMO Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Life Science CDMO Market Size by Region
    • 8.3.1 Asia-Pacific Life Science CDMO Consumption Value by Region (2019-2030)
    • 8.3.2 China Life Science CDMO Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Life Science CDMO Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Life Science CDMO Market Size and Forecast (2019-2030)
    • 8.3.5 India Life Science CDMO Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Life Science CDMO Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Life Science CDMO Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Life Science CDMO Consumption Value by Type (2019-2030)
  • 9.2 South America Life Science CDMO Consumption Value by Application (2019-2030)
  • 9.3 South America Life Science CDMO Market Size by Country
    • 9.3.1 South America Life Science CDMO Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Life Science CDMO Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Life Science CDMO Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Life Science CDMO Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Life Science CDMO Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Life Science CDMO Market Size by Country
    • 10.3.1 Middle East & Africa Life Science CDMO Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Life Science CDMO Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Life Science CDMO Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Life Science CDMO Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Life Science CDMO Market Drivers
  • 11.2 Life Science CDMO Market Restraints
  • 11.3 Life Science CDMO Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Life Science CDMO Industry Chain
  • 12.2 Life Science CDMO Upstream Analysis
  • 12.3 Life Science CDMO Midstream Analysis
  • 12.4 Life Science CDMO Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Life Science CDMO. Industry analysis & Market Report on Life Science CDMO is a syndicated market report, published as Global Life Science CDMO Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Life Science CDMO market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,735.28
    		4,102.92
    		5,470.56
    		3,208.56
    		4,812.84
    		6,417.12
    		547,021.20
    		820,531.80
    		1,094,042.40
    		290,336.40
    		435,504.60
    		580,672.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo